Trial Profile
Antagonist to Gonadotropin-Releasing Hormone in Rheumatoid Arthritis (AGRA): A Double-Blind, Randomized, Placebo Controlled Trial.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Cetrorelix (Primary) ; Disease-modifying antirheumatics
- Indications Rheumatoid arthritis
- Focus Proof of concept; Therapeutic Use
- Acronyms AGRA
- 30 Oct 2013 Results presented at the 77th American College of Rheumatology and the 48th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 14 Nov 2012 Results presented at the 76th Annual Scientific Meeting of the American College of Rheumatology and the 47th Annual Meeting of the Association of Rheumatology and Health Professionals.
- 11 Nov 2012 Primary endpoint 'C-reactive-protein' has not been met.